Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Veliparib, Radiation Therapy, and Temozolomide in Newly Diagnosed High-Grade Glioma
NCT03581292Phase 2Active, not recruiting
- Sponsor
- Children's Oncology Group
- Start
- Nov 2018
- Primary completion
- Mar 2023
- Modality
- Small Molecules
- Countries
- 5
01
Overview
A Phase 2 trial of veliparib in glioma, sponsored by Children's Oncology Group. Started Nov 2018; status: active, not recruiting.
02
Drugs
veliparib
03
Conditions
glioma
Beyond the preview
Go deeper on NCT03581292.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03581292.